← Back to Search

Behavioural Intervention

eSOC Program + FBT for Childhood Obesity (TEAM UP Trial)

N/A
Waitlist Available
Led By Stephen Cook, MD, MPH
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
have a BMI percentile ≥95th for age and sex;
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

TEAM UP Trial Summary

This trial is testing two different approaches to childhood obesity screening and counseling, to find out which is more effective. One approach is family-based behavioral treatment (FBT), which targets both child and parents. The other is a staged approach, which begins with prevention counseling by the primary care provider (PCP) and includes assessment of weight status, patient/family motivation and readiness to change, promotion of healthy eating and activity habits, and use of health behavior change strategies.

Who is the study for?
This trial is for children aged 6 years and older who are obese (BMI ≥95th percentile for age and sex), patients of a participating clinic, comfortable with English, willing to change their lifestyle, and can attend scheduled sessions. It focuses on diverse groups including Black children and those insured by Medicaid.Check my eligibility
What is being tested?
The study compares two approaches: an enhanced standard of care (eSOC) alone versus eSOC combined with Family-based Behavioral Treatment (FBT). The goal is to determine the best method for managing childhood obesity in primary care settings among underserved populations.See study design
What are the potential side effects?
Since this trial involves behavioral interventions like diet changes, increased physical activity, and counseling rather than medication, side effects may include initial discomfort adjusting to new habits or emotional responses during treatment.

TEAM UP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My BMI is in the top 5% for my age and sex.

TEAM UP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Child percent overweight

TEAM UP Trial Design

2Treatment groups
Active Control
Group I: Enhanced Standard of Care (eSOC)Active Control1 Intervention
This group will receive the eSOC program. A minimum of 6 visits to the primary care provider (PCP) and includes assessment of weight status, patient/family motivation and readiness to change, promotion of healthy eating and activity habits, and use of health behavior change strategies.
Group II: Family-Based Behavioral Treatment (FBT + eSOC)Active Control2 Interventions
This group will receive eSOC plus the FBT program. Family-based behavioral treatment (FBT), an effective treatment that targets both child and parents meeting regularly with a health coach for healthy eating, activity, positive parenting strategies, and managing environmental cues.

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,931 Previous Clinical Trials
2,298,249 Total Patients Enrolled
77 Trials studying Obesity
12,357 Patients Enrolled for Obesity
Patient-Centered Outcomes Research InstituteOTHER
549 Previous Clinical Trials
29,995,088 Total Patients Enrolled
17 Trials studying Obesity
3,383,207 Patients Enrolled for Obesity
Blue Cross and Blue Shield of LouisianaUNKNOWN

Media Library

eSOC program (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT03843424 — N/A
Obesity Research Study Groups: Enhanced Standard of Care (eSOC), Family-Based Behavioral Treatment (FBT + eSOC)
Obesity Clinical Trial 2023: eSOC program Highlights & Side Effects. Trial Name: NCT03843424 — N/A
eSOC program (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03843424 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people are participating in this clinical experiment?

"Affirmative. According to clinicaltrials.gov, this clinical trial is actively seeking participants and was initially posted on September 12th 2019 with a most recent update occurring on October 12th 2022. 728 people are being recruited from seven different sites for the study."

Answered by AI

Are there still openings in this clinical experiment for participants?

"Yes, according to clinicaltrials.gov information, this research is currently seeking participants. Initially published on September 12th 2019 and recently updated as of October 12th 2022, the study requires 728 volunteers from seven different sites."

Answered by AI

Could I potentially partake in this medical study?

"This clinical trial seeks 728 youths between 6 and 15 years of age with a BMI percentile above the 95th percentile. Those interested must demonstrate fluency in English, provide either verbal or written consent (dependent on their age), be registered at one of the participating clinics, show willingness to modify dietary choices/physical activity/weight, and commit to attending scheduled sessions."

Answered by AI

How many sites are currently administering this trial?

"Patients can be enrolled in this trial at the University of Rochester Medical Center, located in Cape Girardeau; The University of Missouri School of Medicine, based out of Saint Louis; and Pennington Biomedical Research Centre, situated in Rochester. Additionally, there are 7 other sites providing access to this study."

Answered by AI

Who else is applying?

What site did they apply to?
Pennington Biomedical Research Center
University of Rochester Medical Center
What portion of applicants met pre-screening criteria?
Met criteria
~76 spots leftby Jul 2024